Drug Patents

     Amgen and Wyeth’s “Enbrel” violates a patent on “Anti-TNF antibodies and Methotrexate in the treatment of arthritis and Crohn’s disease,” The Mathilda and Terence Kennedy Institute of Rheumatology Trust claims in Delaware Federal Court.

Exit mobile version